Blood test may help identify patients at risk for transthyretin amyloid cardiomyopathy

FHS
July 29, 2023
1:21 am

A new multi-center study led by doctors at Boston Medical Center and Columbia University found that having a genetic variant in the prealbumin gene alone is not sufficient for diagnosis of transthyretin amyloid cardiomyopathy in older Black patients.

AI-driven biotech Iambic snags $100M to enter the clinic next year in HER2 field

Another AI-driven biotech has reeled in Series B funding, with Iambic Therapeutics disclosing a $100 million round a week after Evozyne nabbed $81 million. Both

October 4, 2023

Ipsen outlines $461m for ex-US rights to Day One’s glioma therapy

Day One’s Ojemda received accelerated approval from the US FDA to treat low-grade glioma in paediatric patients aged six months and older. Image Credit: Lightspring

July 25, 2024

New evidence challenges hype surrounding cancer blood test

New evidence published by The BMJ today casts doubt on a much-hyped blood test for the NHS that promises to detect more than 50 types

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.